$CBUS
Cibus, Inc.

2020 Q2 Form 10-Q Financial Statement

#000156459020036953 Filed on August 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $2.307M $408.0K $157.0K
YoY Change 465.44% 108.16% 1327.27%
Cost Of Revenue $5.321M $303.0K $34.00K
YoY Change 1656.11%
Gross Profit -$3.014M $105.0K $123.0K
YoY Change -2970.48% -46.43% 1018.18%
Gross Profit Margin -130.65% 25.74% 78.34%
Selling, General & Admin $5.167M $6.408M $5.241M
YoY Change -19.37% 39.46% 95.85%
% of Gross Profit 6102.86% 4260.98%
Research & Development $2.825M $2.738M $2.219M
YoY Change 3.18% -11.48% 111.74%
% of Gross Profit 2607.62% 1804.07%
Depreciation & Amortization $450.0K $350.0K $342.0K
YoY Change 28.57% 62.79% 119.23%
% of Gross Profit 333.33% 278.05%
Operating Expenses $8.034M $9.597M $7.646M
YoY Change -16.29% 24.83% 77.52%
Operating Profit -$11.05M -$9.492M -$7.523M
YoY Change 16.39% 26.7% 75.12%
Interest Expense $371.0K $370.0K $370.0K
YoY Change 0.27% -613.89% 57.45%
% of Operating Profit
Other Income/Expense, Net -$8.000K
YoY Change
Pretax Income -$10.90M -$9.403M -$7.375M
YoY Change 15.94% 24.12% 68.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.90M -$9.403M -$7.375M
YoY Change 15.94% 24.12% 68.76%
Net Earnings / Revenue -472.56% -2304.66% -4697.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$329.9K -$287.2K -$225.8K
COMMON SHARES
Basic Shares Outstanding 33.04M 32.70M shares 32.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.80M $76.40M $84.20M
YoY Change -55.76% -27.65% 66.07%
Cash & Equivalents $3.875M $76.43M $84.23M
Short-Term Investments $29.90M
Other Short-Term Assets $2.300M $1.900M $2.200M
YoY Change 21.05% 26.67% 4.76%
Inventory $5.282M $100.0K $379.0K
Prepaid Expenses
Receivables $2.411M $800.0K $124.0K
Other Receivables $0.00 $100.0K $200.0K
Total Short-Term Assets $43.80M $79.30M $87.02M
YoY Change -44.77% -26.02% 64.72%
LONG-TERM ASSETS
Property, Plant & Equipment $22.70M $22.50M $21.85M
YoY Change 0.89% 5.45% 16.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.500M $1.800M $674.0K
YoY Change -16.67% 486.32% 149.63%
Total Long-Term Assets $24.20M $24.30M $23.65M
YoY Change -0.41% 12.27% 24.22%
TOTAL ASSETS
Total Short-Term Assets $43.80M $79.30M $87.02M
Total Long-Term Assets $24.20M $24.30M $23.65M
Total Assets $68.00M $103.6M $110.7M
YoY Change -34.36% -19.59% 53.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K $400.0K $724.0K
YoY Change 50.0% -63.96% 64.17%
Accrued Expenses $3.300M $3.200M $1.610M
YoY Change 3.13% 63.35% 28.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $300.0K $300.0K
YoY Change 33.33%
Total Short-Term Liabilities $4.600M $5.000M $4.650M
YoY Change -8.0% -0.83% 56.46%
LONG-TERM LIABILITIES
Long-Term Debt $1.518M $18.30M $18.20M
YoY Change -91.7% 5.17% 22.97%
Other Long-Term Liabilities $100.0K $200.0K $156.0K
YoY Change -50.0% 100.0% -48.0%
Total Long-Term Liabilities $1.518M $18.50M $156.0K
YoY Change -91.79% 5.71% -98.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.600M $5.000M $4.650M
Total Long-Term Liabilities $1.518M $18.50M $156.0K
Total Liabilities $24.40M $23.40M $22.97M
YoY Change 4.27% 3.53% 27.55%
SHAREHOLDERS EQUITY
Retained Earnings -$144.0M -$89.82M
YoY Change 52.45%
Common Stock $177.8M
YoY Change 57.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.55M $80.19M $87.70M
YoY Change
Total Liabilities & Shareholders Equity $67.96M $103.6M $110.7M
YoY Change -34.4% -19.59% 53.99%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$10.90M -$9.403M -$7.375M
YoY Change 15.94% 24.12% 68.76%
Depreciation, Depletion And Amortization $450.0K $350.0K $342.0K
YoY Change 28.57% 62.79% 119.23%
Cash From Operating Activities -$13.42M -$6.590M -$9.276M
YoY Change 103.64% 191.59% 41.29%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$970.0K $346.0K
YoY Change -79.38% 110.87% 743.9%
Acquisitions
YoY Change
Other Investing Activities $8.680M $0.00
YoY Change
Cash From Investing Activities $8.480M -$970.0K -$346.0K
YoY Change -974.23% 110.87% 743.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.440M -230.0K 66.00K
YoY Change -726.09% -100.4% -89.77%
NET CHANGE
Cash From Operating Activities -13.42M -6.590M -9.276M
Cash From Investing Activities 8.480M -970.0K -346.0K
Cash From Financing Activities 1.440M -230.0K 66.00K
Net Change In Cash -3.500M -7.790M -9.556M
YoY Change -55.07% -114.19% 60.31%
FREE CASH FLOW
Cash From Operating Activities -$13.42M -$6.590M -$9.276M
Capital Expenditures -$200.0K -$970.0K $346.0K
Free Cash Flow -$13.22M -$5.620M -$9.622M
YoY Change 135.23% 212.22% 45.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q4 us-gaap Liabilities
Liabilities
25590000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
303000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
8024000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
9597000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11038000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9492000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
154000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
92000
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10902000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9403000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10902000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9403000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33039338
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32732988
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144022000
CY2020Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67961000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
43553000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1518000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
185588000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122057000
CY2019Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9205000
CY2020Q2 us-gaap Gross Profit
GrossProfit
-3014000
CY2019Q2 us-gaap Gross Profit
GrossProfit
105000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2825000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
566000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
87703000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9403000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2304000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-38000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88098000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4684000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33033689
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32951329
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
82360
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62508000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5321000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
337000
us-gaap Gross Profit
GrossProfit
-4521000
us-gaap Gross Profit
GrossProfit
229000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2738000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5612000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4957000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1349000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1202000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2929000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2107000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3808000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5206000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8528000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9368000
CY2020Q2 clxt Management Fees
ManagementFees
42000
CY2019Q2 clxt Management Fees
ManagementFees
451000
clxt Management Fees
ManagementFees
104000
clxt Management Fees
ManagementFees
812000
us-gaap Operating Expenses
OperatingExpenses
17173000
us-gaap Operating Expenses
OperatingExpenses
17244000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21694000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17015000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-244000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
264000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21965000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16778000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Net Income Loss
NetIncomeLoss
-21965000
us-gaap Net Income Loss
NetIncomeLoss
-16778000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33013739
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32704834
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
93397000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
52536000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10902000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1797000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
122000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
43553000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
183000
CY2019Q2 clxt Value Of Shares Withheld For Net Share Settlement
ValueOfSharesWithheldForNetShareSettlement
559000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
80190000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62508000
us-gaap Net Income Loss
NetIncomeLoss
-21965000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3068000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-58000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
43553000
us-gaap Net Income Loss
NetIncomeLoss
-16778000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3860000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
308000
clxt Value Of Shares Withheld For Net Share Settlement
ValueOfSharesWithheldForNetShareSettlement
559000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-38000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
80190000
us-gaap Profit Loss
ProfitLoss
-21965000
us-gaap Profit Loss
ProfitLoss
-16778000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
904000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
689000
us-gaap Share Based Compensation
ShareBasedCompensation
3068000
us-gaap Share Based Compensation
ShareBasedCompensation
3860000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1289000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
810000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-598000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-1156000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2688000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
111000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1118000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
169000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-505000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-423000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-546000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-14000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-888000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-67000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-93000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-513000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-59000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
378000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25659000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15870000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
29942000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
517000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1319000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30459000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1319000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1518000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
130000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
122000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
308000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
559000
clxt Proceeds From Sale And Lease Back Of Land Buildings And Equipment
ProceedsFromSaleAndLeaseBackOfLandBuildingsAndEquipment
217000
CY2020Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
15364000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1388000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-54730000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17345000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95288000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5308000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77943000
CY2020Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
30778000
CY2019Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
62000
CY2019Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
15651000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
29942000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10902000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9403000
us-gaap Net Income Loss
NetIncomeLoss
-21965000
us-gaap Net Income Loss
NetIncomeLoss
-16778000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33039338
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32732988
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33013739
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32704834
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5140153
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5592441
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2064594
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1789567
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.73
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4481359
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
60000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
357531
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.03
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2028498
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.33
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4183828
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.39
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
183000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
308000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
527000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
880000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9000000.0
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2211000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
553000
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
23000
CY2019Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
20000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
47000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
69000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
34200000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3875000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76434000
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
1433000
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
1509000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5308000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77943000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
29942000
CY2020Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
35250000
us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
We provide a 401(k) defined contribution plan for all regular full-time employees who have completed three months of service.
CY2020Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
78000
CY2019Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
49000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
198000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
105000
CY2020Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1458000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1247000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
235000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
125000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2411000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1122000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4326000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
272000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
403000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
111000
CY2020Q2 us-gaap Inventory Net
InventoryNet
5282000
CY2019Q4 us-gaap Inventory Net
InventoryNet
2594000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1797000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2304000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3068000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3860000
CY2020Q2 us-gaap Interest Expense
InterestExpense
371000
CY2019Q2 us-gaap Interest Expense
InterestExpense
370000
us-gaap Interest Expense
InterestExpense
743000
us-gaap Interest Expense
InterestExpense
740000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
525000
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
462000
us-gaap Investment Income Net
InvestmentIncomeNet
499000
us-gaap Investment Income Net
InvestmentIncomeNet
1004000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
154000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
92000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-244000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
264000
CY2019Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
77943000
us-gaap Interest Paid
InterestPaid
732000
us-gaap Interest Paid
InterestPaid
737000

Files In Submission

Name View Source Status
0001564590-20-036953-index-headers.html Edgar Link pending
0001564590-20-036953-index.html Edgar Link pending
0001564590-20-036953.txt Edgar Link pending
0001564590-20-036953-xbrl.zip Edgar Link pending
clxt-10q_20200630.htm Edgar Link pending
clxt-10q_20200630_htm.xml Edgar Link completed
clxt-20200630.xsd Edgar Link pending
clxt-20200630_cal.xml Edgar Link unprocessable
clxt-20200630_def.xml Edgar Link unprocessable
clxt-20200630_lab.xml Edgar Link unprocessable
clxt-20200630_pre.xml Edgar Link unprocessable
clxt-ex101_186.htm Edgar Link pending
clxt-ex102_185.htm Edgar Link pending
clxt-ex103_184.htm Edgar Link pending
clxt-ex311_7.htm Edgar Link pending
clxt-ex312_6.htm Edgar Link pending
clxt-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gduzswarmcix000001.jpg Edgar Link pending
giurgazjnrcx000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending